YMAB

Y mAbs Therapeutics Stock Price

35.05
-1.32 (-3.63%)
Upgrade to Real-Time
Regular Market
35.05

Low
24.775

52 Week Range

High
55.36

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Y mAbs Therapeutics Inc YMAB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.32 -3.63% 35.05 14:37:47
Open Price Low Price High Price Close Price Prev Close
36.19 34.22 36.88 36.37
Bid Price Ask Price Spread News
34.98 35.04 0.06 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,772 116,604 $ 35.47 $ 4,135,528 271,342 24.775 - 55.36
Last Trade Time Type Quantity Stock Price Currency
14:39:07 1 $ 35.01 USD

Y mAbs Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.53B 43.57M 34.63M $ 20.75M $ - -2.97 -23.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.10M 1.00%

more financials information »

Y mAbs Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical YMAB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week35.0738.3933.9936.55279,850-0.02-0.06%
1 Month33.5038.3932.8035.59239,6561.554.63%
3 Months35.1238.3924.77531.12278,350-0.07-0.2%
6 Months52.3754.860324.77537.30283,519-17.32-33.07%
1 Year41.1655.3624.77539.58231,485-6.11-14.84%
3 Years26.5055.3614.1633.01194,2828.5532.26%
5 Years26.5055.3614.1633.01194,2828.5532.26%

Y mAbs Therapeutics Description

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others.
Your Recent History
NASDAQ
YMAB
Y mAbs The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210615 18:54:20